Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I–II Inhibition Properties, and In Silico Studies

Mays Faris; Hayrani Eren Bostancı; İbrahim Özcan; Mustafa Ozturk; Ümit Muhammed Koçyiğit; Taner Erdoğan; Hakan Tahtaci

doi:10.1021/acsomega.4c00028

journal article Open Access May 03, 2024

Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I–II Inhibition Properties, and In Silico Studies

Mays Faris Hayrani Eren Bostancı

İbrahim Özcan Mustafa Ozturk Ümit Muhammed Koçyiğit Taner Erdoğan Hakan Tahtaci

ACS Omega Vol. 9 No. 19 pp. 20937-20956 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acsomega.4c00028

Topics

No keywords indexed for this article. Browse by subject →

References

97

[1]

10.1016/j.ejmech.2012.08.012

[2]

10.1080/00397911.2020.1797814

[3]

10.1016/j.tet.2020.130951

[4]

Mishra G. J. Appl. Pharm. Sci. (2011)

[5]

10.1002/cbdv.202200884

[6]

10.1016/j.jphs.2021.05.004

[7]

10.2174/1386207320666170110141907

[8]

10.1007/s00436-020-06668-6

[9]

10.1128/aac.02156-18

[10]

10.1007/bf03246164

[11]

10.1016/j.ejmech.2008.08.010

[12]

10.1016/j.bmcl.2007.10.111

[13]

10.1016/j.ejmech.2008.01.006

[14]

10.1002/jccs.201900165

[15]

10.1016/j.bmc.2017.09.037

[16]

10.1016/j.antiviral.2017.06.007

[17]

10.1016/s0014-827x(01)01076-x

[18]

10.1016/j.ejmech.2010.04.015

[19]

10.1016/s0968-0896(02)00327-9

[20]

10.1016/s0960-894x(02)00289-5

[21]

10.1021/jm900356n

[22]

10.1002/ardp.202200132

[23]

10.25092/baunfbed.340617

[24]

10.21597/jist.407875

[25]

10.2174/138161208783877947

[26]

10.3390/molecules27092796

[27]

10.3897/pharmacia.70.e101989

[28]

10.1016/j.ijbiomac.2023.126084

[29]

10.1016/j.molstruc.2023.136341

[30]

10.2174/1570180817999201005200505

[31]

10.3109/14756366.2015.1063624

[32]

10.1002/cbdv.202200886

[33]

10.1016/j.compbiolchem.2022.107779

[34]

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al.

Advanced Drug Delivery Reviews 10.1016/s0169-409x(96)00423-1

[35]

10.1021/cc9800071

[36]

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung-Yuan Cheng et al.

Journal of Medicinal Chemistry 10.1021/jm020017n

[37]

Prediction of Drug Absorption Using Multivariate Statistics

William J. Egan, Kenneth M. Merz,, John J. Baldwin

Journal of Medicinal Chemistry 10.1021/jm000292e

[38]

Simple Selection Criteria for Drug-like Chemical Matter

Ingo Muegge, Sarah L. Heald, David Brittelli

Journal of Medicinal Chemistry 10.1021/jm015507e

[39]

Ganguly S. Asian J. Chem. (2008)

[40]

Butan M. Stud. Univ. Babes-Bolyai, Chem. (1995)

[41]

Godefroi, E. F.; Heeres, J., L- (ß-Aryl) ethylimidazole derivatives, their preparation and fungicidal and bactericidal agents containing them. U.S. Patent US 3717655A, 1969.

[42]

Godefroi, E. F.; Josephus, L. C. M. Imidazoldenvate. DE 1920635B2, 1970.

[43]

Janssen Pharmaceutica, N. V., Imidazole Derivatives. U.S. Patent US 5116984A, 1969.

[44]

Weiyuan, Z.; Kangzhou, P.; Kai, S.; Mengya, C.; Xiao, C.; Yu, L. O-Allylation Method of α-Diaryl Substituted Ethanol. 2019.

[45]

Yoneta, T.; Fujii, N.; Ooishi, M.; Iinuma, K.; Sato, A.; Yasuda, K. Anti-mrsa composition. EP0666077A1, 1994.

[46]

10.1021/jm00305a014

[47]

10.1080/1062936x.2023.2240698

[48]

The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay

Iris F.F. Benzie, J.J. Strain

Analytical Biochemistry 10.1006/abio.1996.0292

[49]

Albayrak S. Erciyes Üniv. Fen Bilim. Enst. Derg. (2010)

[50]

10.1016/s0021-9258(18)95800-x

Showing 50 of 97 references

Cited By

14

Synthesis of Heterocyclic Chalcone Analogues Containing Chromene and 1-Hydroxyimidazole Moieties

Elizaveta I. Basanova, Ekaterina M. Kulinich · 2025

Russian Journal of General Chemistr...

Oxidative Coupling of Guanidines and Isocyanides Catalyzed by Nickel(II): Access to Imidazoline Derivatives with Antibacterial Activity

Georgii A. Gavrilov, Tuan K. Nguyen · 2025

ChemMedChem

Metrics

14

Citations

97

References

Details

Published: May 03, 2024
Vol/Issue: 9(19)
Pages: 20937-20956
License: View

Authors

M

Mays Faris

Department of Chemistry, Faculty of Science, Karabuk University, 78050 Karabuk, Türkiye

H

Hayrani Eren Bostancı

Department of Biochemistry Sivas, Faculty of Pharmacy, Sivas Cumhuriyet University, 58010 Sivas, Türkiye

�

İbrahim Özcan

Department of Chemistry, Faculty of Science, Karabuk University, 78050 Karabuk, Türkiye

M

Mustafa Ozturk

Sivas Vocational School of Technical Sciences, Sivas Cumhuriyet University, 58010 Sivas, Türkiye

�

Ümit Muhammed Koçyiğit

Department of Biochemistry Sivas, Faculty of Pharmacy, Sivas Cumhuriyet University, 58010 Sivas, Türkiye

T

Taner Erdoğan

Kocaeli Vocational School, Department of Chemistry and Chemical Processing Technologies, Kocaeli University, 41140 Kocaeli, Türkiye

H

Hakan Tahtaci

Department of Chemistry, Faculty of Science, Karabuk University, 78050 Karabuk, Türkiye

Cite This Article

Mays Faris, Hayrani Eren Bostancı, İbrahim Özcan, et al. (2024). Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I–II Inhibition Properties, and In Silico Studies. ACS Omega, 9(19), 20937-20956. https://doi.org/10.1021/acsomega.4c00028

Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I–II Inhibition Properties, and In Silico Studies

You May Also Like